•  
  •  
 

Abstract

Hypertension is widely known as cardiovascular disease. In addition to resulting heart failure, hypertension can result in kidney failure and cerebrovascular disease. This study was aimed to determine the percentage of treatment rationality of hypertensive patient treatment outpatient in Puskesmas Siantan Hilir Pontianak 2015 which includes the appropriate indication, appropriate drug, appropriate patient, and appropriate dose based on the guideline JNC 7. This study was cross-sectional study using medical records of outpatient hypertension patients in 2015. The total of sample analyzed in this research were 92 medical records of hypertension patients from 118 medical records. The percentage of using the angiotensin converting enzym inhibitor (captopril) was 47.46%; calcium channel blocker (amlodipine) was 34.75%; thiazid diuretic (hydrochlorothiazid) was 16.10%; loop diuretic (furosemid) was 0.85%; and potassium sparing (spironolactone) was 0.85%. The rasionality of hypertensive therapy in patients in this study were 100% appropriate indication; 70.65% appropriate drug; 100% appropriate patient; and 98.91% appropriate dose. The conclusion of this study is that overall treatment that meets all four rational treatment criterias was 69.56%.

Bahasa Abstract

Hipertensi dikenal secara luas sebagai penyakit kardiovaskular. Selain mengakibatkan gagal jantung, hipertensi dapat berakibat terjadinya gagal ginjal maupun penyakit serebrovaskular. Penelitian ini bertujuan untuk mengetahui penggunaan obat dan rasionalitas pengobatan pasien hipertensi rawat jalan di Puskesmas Siantan Hilir Pontianak Tahun 2015 yang meliputi tepat indikasi, tepat obat, tepat pasien, dan tepat dosis berdasarkan pedoman JNC 7. Penelitian ini merupakan studi observasional potong lintang menggunakan data retrospektif berupa rekam medis pasien hipertensi rawat jalan selama tahun 2015. Sampel yang dianalisis adalah 92 rekam medis pasien hipertensi dari 118 rekam medis. Persentase penggunaan obat antihipertensi yaitu golongan penghambat enzim konversi angiotensin (kaptopril) sebesar 47,46%; penghambat kanal kalsium (amlodipin) sebesar 34,75%; diuretik tiazid (hidroklorotiazid) sebesar 16,10%; diuretik kuat (furosemid) sebesar 0,85%; dan diuretik hemat kalium (spironolakton) sebesar 0,85%. Rasionalitas pengobatan pasien hipertensi yang memenuhi tepat indikasi sebesar 100%; tepat obat 70,65%; tepat pasien 100%; dan tepat dosis 98,91%. Secara keseluruhan pengobatan yang memenuhi keempat kriteria pengobatan yang rasional sebesar 69,56%.

References

Chobaniam AV et al. (2003). Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. JAMA, 289, 2560-2572

Departemen Kesehatan RI. (2011). Kebijakan obat nasional. Jakarta: Departemen Kesehatan RI

Dinas Kesehatan Kota Pontianak. (2015). Profil Kesehatan Kota Pontianak 2014. Pontianak: Dinas Kesehatan Kota Pontianak.

Dinas Kesehatan Kota Pontianak. (2011). Profil Kesehatan Kota Pontianak 2010. Pontianak: Dinas Kesehatan Kota Pontianak.

Dipiro JT, Talbert RL, Yee GC, Matzke GR, Wells BG, Posey LM. (2008). Pharmacotherapy: A Phatophysiologic Approach. Seventh Edition. USA: MC Graw-Hill.

Hilal-Dandan R, & Brunton L. (2013). Goodman and Gilman manual of pharmacology and therapeutics. McGraw Hill Professional.

Kardela W, Andrajati R, Sudibyo S. (2014). Perbandingan penggunaan obat rasional berdasarkan indikator WHO di puskesmas kecamatan antara kota Depok dan Jakarta Selatan. Jurnal Kefarmasian Indonesia, 4 (2), 91-102.

Kemenkes RI. (2011). Modul penggunaan obat rasional. Jakarta: Kementrian Kesehatan RI. Kemenkes RI. (2013). Laporan riskesdas 2013. Jakarta: Badan Litbangkes Kemenkes RI.

Oktora R. (2007). Gambaran penderita hipertensi yang dirawat inap di bagian penyakit dalam RSUD Arifin Achmad Pekanbaru periode Januari sampai Desember 2005. Skripsi. FK UNRI.

Oparil S, Zaman MA, Calhoun DA. (2003). Pathogenesis of hypertension. Ann Intern Med, 139, 761-776.

Rosano GMC, Vitale C, Marazzi G, Volterrani M. (2007). Menopause and cardiovascular disease: The evidence. Climacteric, 10(sup1), 19-24.

World Health Organization. (1993). How to investigate drug use in health facilities. Geneva: World Health Organization.

World Health Organization. (1999). Indicators for monitoring national drug policy. (2nd ed). Geneva

World Health Organization. (2004). Promoting rational use of medicines saves lives and money WHO experts say. Geneva.

World Health Organization. (2002). Promoting rational use of medicines: core components. Geneva

Download

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.